X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (109) 109
index medicus (92) 92
male (82) 82
rats (81) 81
inflammation (65) 65
rats, wistar (62) 62
mice (45) 45
disease models, animal (37) 37
pharmacology & pharmacy (37) 37
cytokines (34) 34
oxidative stress (25) 25
peroxidase - metabolism (25) 25
immunohistochemistry (24) 24
rodents (24) 24
tumor necrosis factor-alpha - metabolism (24) 24
analysis (23) 23
nitric oxide (22) 22
nitric-oxide (22) 22
activation (21) 21
pathogenesis (21) 21
research (21) 21
expression (20) 20
research article (20) 20
chemotherapy (19) 19
dose-response relationship, drug (19) 19
medicine (19) 19
humans (18) 18
inhibition (18) 18
periodontitis (18) 18
dentistry, oral surgery & medicine (17) 17
immunology (17) 17
pharmacology/toxicology (17) 17
cancer (16) 16
dentistry (16) 16
mucositis (16) 16
necrosis-factor-alpha (16) 16
tnf-alpha (16) 16
interleukin-1beta - metabolism (15) 15
multidisciplinary sciences (15) 15
oncology (15) 15
antioxidants (14) 14
disease (14) 14
health aspects (14) 14
neurosciences (14) 14
science (14) 14
cytokines - metabolism (13) 13
female (13) 13
periodontitis - drug therapy (13) 13
physiological aspects (13) 13
proteins (13) 13
tumor necrosis factor (13) 13
5-fluorouracil (12) 12
biomedicine (12) 12
cell biology (12) 12
prevention (12) 12
care and treatment (11) 11
diarrhea (11) 11
fluorouracil (11) 11
gene expression (11) 11
medicine & public health (11) 11
mucositis - chemically induced (11) 11
nitric oxide synthase type ii - metabolism (11) 11
alveolar bone loss - drug therapy (10) 10
anti-inflammatory agents - therapeutic use (10) 10
edema - chemically induced (10) 10
mechanisms (10) 10
oxidative stress - drug effects (10) 10
physiology (10) 10
surgery (10) 10
alveolar bone loss - prevention & control (9) 9
arthritis (9) 9
camptothecin - analogs & derivatives (9) 9
cancer research (9) 9
cells (9) 9
complications and side effects (9) 9
cyclooxygenase 2 - metabolism (9) 9
cyclooxygenase-2 (9) 9
drug therapy (9) 9
enzyme-linked immunosorbent assay (9) 9
in-vitro (9) 9
inflammation - drug therapy (9) 9
intestinal mucosa - pathology (9) 9
morphology (9) 9
neutrophils - drug effects (9) 9
nitric-oxide synthase (9) 9
peroxidase (9) 9
time factors (9) 9
alveolar bone loss (8) 8
alveolar bone loss - pathology (8) 8
apoptosis (8) 8
cricetinae (8) 8
inflammation - chemically induced (8) 8
intestinal mucosa - drug effects (8) 8
irinotecan (8) 8
laboratory animals (8) 8
medicine and health sciences (8) 8
model (8) 8
neutrophil migration (8) 8
pharmacology (8) 8
random allocation (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Periodontology, ISSN 0022-3492, 08/2013, Volume 84, Issue 8, pp. 1145 - 1157
Background: Simvastatin is a cholesterol‐lowering drug whose pleiotropic effects may have a therapeutic impact on bone. This study evaluates the effect of... 
hydroxymethylglutaryl‐CoA reductase inhibitors | inflammation | Alveolar bone loss | periodontitis | Inflammation | Hydroxymethylglutaryl-CoA reductase inhibitors | Periodontitis | OVARIECTOMIZED RATS | STATINS | IN-VITRO | METABOLISM | DENTISTRY, ORAL SURGERY & MEDICINE | NITRIC-OXIDE | hydroxymethylglutaryl-CoA reductase inhibitors | MEVALONATE PATHWAY | KAPPA-B LIGAND | PROTEIN PRENYLATION | Interleukin-1beta - drug effects | Simvastatin - therapeutic use | Bone Morphogenetic Protein 2 - drug effects | Rats, Wistar | Matrix Metalloproteinase 8 - drug effects | Alveolar Bone Loss - prevention & control | Receptor Activator of Nuclear Factor-kappa B - drug effects | RANK Ligand - drug effects | Malondialdehyde - analysis | Alanine Transaminase - drug effects | Gingiva - drug effects | Glutathione - drug effects | Anti-Inflammatory Agents - therapeutic use | Female | Osteoprotegerin - drug effects | Interleukin-10 - analysis | Nitrates - analysis | Peroxidase - drug effects | Matrix Metalloproteinase 1 - drug effects | Nitric Oxide Synthase Type II - drug effects | Rats | Aspartate Aminotransferases - drug effects | Alkaline Phosphatase - drug effects | Periodontitis - prevention & control | Antioxidants - therapeutic use | Animals | Tumor Necrosis Factor-alpha - drug effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Nitrites - analysis | Oxidative Stress - drug effects
Journal Article
Anais Brasileiros de Dermatologia, ISSN 0365-0596, 08/2003, Volume 78, Issue 4, pp. 425 - 434
FUNDAMENTOS: O processo de envelhecimento tecidual é evidente nas modificações visíveis na pele, resultando em importantes implicações psicológicas para o... 
Journal Article
Anais Brasileiros de Dermatologia, ISSN 0365-0596, 08/2003, Volume 78, Issue 4, pp. 425 - 434
FUNDAMENTOS: O processo de envelhecimento tecidual é evidente nas modificações visíveis na pele, resultando em importantes implicações psicológicas para o... 
envelhecimento | epiderme | envelhecimento da pele | skin | derme | pele | skin aging | aging | dermis | epidermis
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2014, Volume 9, Issue 12, p. e113378
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2015, Volume 10, Issue 10, pp. e0139985 - e0139985
Intestinal mucositis is a common side effect of irinotecan-based anticancer regimens. Mucositis causes cell damage, bacterial/endotoxin translocation and... 
ACTIVATION | INFLAMMATORY-BOWEL-DISEASE | CANCER-CHEMOTHERAPY | CHEMOTHERAPY-INDUCED DIARRHEA | NITRIC-OXIDE SYNTHASE | MULTIDISCIPLINARY SCIENCES | TOLL-LIKE RECEPTORS | FACTOR-KAPPA-B | TNF-ALPHA | TLR | EXPRESSION | Mucositis - metabolism | Toll-Like Receptor 2 - genetics | Intestinal Diseases - chemically induced | Toll-Like Receptor 9 - genetics | Intestines - metabolism | Diarrhea - chemically induced | Camptothecin - analogs & derivatives | Myeloid Differentiation Factor 88 - genetics | Intestinal Diseases - genetics | Toll-Like Receptor 2 - metabolism | Bacteremia - genetics | Intestinal Diseases - metabolism | Mucositis - chemically induced | Mice, Knockout | Bacteremia - metabolism | Animals | Bacteremia - chemically induced | Diarrhea - genetics | Diarrhea - metabolism | Signal Transduction - physiology | Mice | Mucositis - genetics | Toll-Like Receptor 9 - metabolism | Myeloid Differentiation Factor 88 - metabolism | Peroxidase - metabolism | Physiological aspects | Cellular signal transduction | Genetic aspects | Mucositis | Research | Risk factors | Pathogenesis | Life assessment | Kinases | Cancer therapies | Anticancer properties | Proteins | Signal transduction | Receptors | Clonal deletion | Intestine | Rodents | Toll-like receptors | Deletion | Physiology | Peroxidase | Damage accumulation | Euthanasia | Immune system | Translocation | NF-κB protein | Cell survival | TRAF6 protein | Cytokines | Diarrhea | Pharmacology | Inflammation | Forensic medicine | IL-1β | Gene expression | Survival | Ileum | Bacteremia | TLR9 protein | Pathology | Irinotecan | Signaling | Chemotherapy | TLR2 protein | MyD88 protein | Index Medicus
Journal Article
International journal of molecular sciences, ISSN 1422-0067, 11/2018, Volume 19, Issue 11, p. 3488
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2016, Volume 11, Issue 4, p. e0153716
S-nitrosoglutathione (GSNO) is a nitric oxide (NO) donor, which exerts antioxidant, anti-inflammatory, and microbicidal actions. Intragingival application of... 
SYNTHASE | MULTIDISCIPLINARY SCIENCES | NITRIC-OXIDE | PREVENTION | S-NITROSOGLUTATHIONE | EXPRESSION | HYDROGEL | Tumor Necrosis Factor-alpha - metabolism | Inflammation - pathology | Rats, Wistar | Male | Alveolar Bone Loss - drug therapy | Periodontal Diseases - drug therapy | S-Nitrosoglutathione - administration & dosage | Gingiva - metabolism | Inflammation - metabolism | Gingiva - drug effects | Solutions | Inflammation - drug therapy | Interleukin-1beta - metabolism | Receptor Activator of Nuclear Factor-kappa B - metabolism | Disease Models, Animal | Alveolar Bone Loss - metabolism | Rats | Hypromellose Derivatives - administration & dosage | Alveolar Bone Loss - pathology | Nitric Oxide Donors - administration & dosage | Periodontal Diseases - metabolism | Animals | Periodontal Diseases - pathology | Tartrate-Resistant Acid Phosphatase - metabolism | Administration, Topical | Nitric Oxide Synthase Type II - metabolism | Bone resorption | Complications and side effects | Care and treatment | Periodontal disease | Hydroxypropyl cellulose | Inflammation | Health aspects | Risk factors | Oxidative stress | Alkaline phosphatase | Disease | Transcription | Antioxidants | Microbicides | Rodents | Physiology | Bone loss | Periodontics | Therapeutic applications | Alveolar bone | Dentistry | Tumor necrosis factor-α | IL-1β | Cervix | Gene expression | Medicine | Nitric oxide | Morphology | Bone | Topical application
Journal Article
Nutrients, ISSN 2072-6643, 01/2019, Volume 11, Issue 1, p. 208
This study aimed to evaluate the effect of Lactobacillus reuteri DSM 17938 (DSM) on ethanol-induced gastric injury, and if its possible mechanism of action is... 
Probiotic | Alcohol | TRPV | Neurokinin | Gastritis | alcohol | OXIDATIVE STRESS | SUPEROXIDE | PLACEBO | neurokinin | PROBIOTICS | PATHOGENESIS | probiotic | NUTRITION & DIETETICS | METABOLISM | DOUBLE-BLIND | SUBSTANCE-P | NITRITE | gastritis | MUCOSAL DAMAGE | Gastric Mucosa - microbiology | Gastritis - metabolism | Species Specificity | Glutathione - metabolism | Antioxidants - metabolism | Stomach Ulcer - pathology | Gastric Mucosa - pathology | Protective Agents - therapeutic use | Gastric Mucosa - metabolism | Gastritis - prevention & control | TRPV Cation Channels - antagonists & inhibitors | Ethanol - adverse effects | TRPV Cation Channels - pharmacology | Stomach Ulcer - prevention & control | Superoxide Dismutase - metabolism | Diterpenes - pharmacology | Malondialdehyde - metabolism | Stomach Ulcer - chemically induced | Substance P - antagonists & inhibitors | Stomach Ulcer - metabolism | Stomach - pathology | Animals | Gastritis - chemically induced | Lactobacillus reuteri - classification | Lactobacillus reuteri - growth & development | Probiotics - therapeutic use | Mice | Stomach - microbiology | Health care | Oxidative stress | Ethanol | Substance P | Mucosa | Gastric mucosa | Capsaicin receptors | Superoxide dismutase | Superoxide | Hemorrhage | Malondialdehyde | Antioxidants | Transient receptor potential proteins | Injury prevention | Resiniferatoxin | Acids | Activated carbon | Supplementation | Pretreatment | Lesions | Laboratory animals | Constipation | Glutathione
Journal Article
Journal of Clinical Microbiology, ISSN 0095-1137, 04/2015, Volume 53, Issue 4, pp. 1216 - 1226
Journal Article